Intuitive Surgical misses by $0.11, reports revs and da Vinci procedures in line with pre-announcement; will guide for FY19 da Vinci procedures on conference call at 16:30 ET (536.12 +6.17)
Reports Q4 (Dec) earnings of $2.96 per share, excluding non-recurring items, $0.11 worse than the S&P Capital IQ Consensus of $3.07; revenues rose 17.3% year/year to $1.05 bln vs the $1.05 bln S&P Capital IQ Consensus (in line with pre-announcement).
Worldwide da Vinci procedures grew approximately 19% (in line with pre-announcement) compared with the fourth quarter of 2017, driven primarily by growth in U.S. general surgery procedures and worldwide urologic procedures.
The Company shipped 290 da Vinci Surgical Systems compared with 216 in the fourth quarter of 2017.
Co will guide for FY19 da Vinci procedures on conference call at 16:30 E